[ad_1]
As a global healthcare company, its vision is to create a better and healthier day for every woman all over the world. Organon organized a thought leadership panel discussion during the Expo 2020, “Accelerate the promotion of women’s health throughout the region Progress” forum. Together with the American Chamber of Commerce, the American Pavilion, Jhpiego and Friends of Cancer Patients, Organon convened a forum of global experts and industry thought leaders to better understand existing gaps in women’s healthcare and explore potential solutions. Many VIPs attended, including His Excellency Dr. Amin Al Amiri and Megan Gregonis, Consul General of the United States in Dubai. This forum marked the launch of Organon in the MENAT region.
Organon has a diversified product portfolio covering women’s health, biosimilars and well-known brands, and is the only company in the world that focuses on women’s health. In order to shift the focus of female healthcare from female reproduction to unresolved needs, this healthcare company provides 60 drugs and solutions in 140 markets, currently in the UAE, Oman, Kuwait, Qatar, Saudi Arabia, Egypt, Lebanon , Jordan and Turkey to conduct business with Ukraine. According to the UN’s Sustainable Development Goals on gender equality and women’s empowerment, Orgon’s mission is to improve and innovate in the field of women’s healthcare.
Ramy Koussa, Vice President of Organon MENAT, commented on the launch: “Our goal is to promote the health care of MENAT women by addressing the unmet needs of women, helping to build a healthier and brighter future for all women, families and communities. Leverage our existing global footprint and expertise, and Working closely with local authorities and industry stakeholders, we are keen to transform the paradigm of women’s health from reproductive health to cover the entire life cycle. This forum is an important first for us, Organon MENAT, and it provides a platform to Listen to women’s voices and become a trusted female healthcare partner in the region,” he added.
Topics discussed by outstanding female healthcare experts included existing data gaps that hinder the improvement of women’s health, how to monitor progress towards the UN’s sustainable goals for gender equality, healthcare investment, and economic empowerment to accelerate change. The attending panel included: Dr. Susanne Fiedler, Chief Commercial Officer of Organon; Susanne Mikhail, Regional Director of the United Nations Agency for Gender Equality and the Empowerment of Women in Arab Countries; Bathylle Missika, Director of the OECD Development Center Network, Partnerships and Gender Division; Jhpeigo Director of Gender Myra Betron; and Dina El-Shenoufy, Chief Investment Officer of Flat6lab.
Ms. Susanne Mikhail, Regional Director, United Nations Agency for the Promotion of Gender Equality and the Empowerment of Women in Arab Countries, Said: “A better understanding and addressing of women’s unmet health care needs is critical to achieving the sustainable goals of the 2030 Agenda, including the vital goals of gender equality and women’s economic empowerment. In addition to being regarded as a basic right, women’s health is also directly related to economic development. For example, if women’s health problems are resolved, they can add 28 trillion U.S. dollars (or 26% of global GDP) to the global economy by 2025 , Allowing them to participate more fully in the labor market. Therefore, it is great to see Organon focusing on women’s health needs and accelerating the advancement of women’s health in the region.”
Comment after the group discussion, Said Dr. Susanne Fiedler, Chief Commercial Officer of Organon, “At Organon, we are working hard to create a world where every woman can enjoy better health. As a company, it is imperative that we not only listen to women’s opinions, but also learn from them what their current needs are not being met. To this end, we will work closely with industry stakeholders from private to public organizations, healthcare providers, patient associations, etc., to establish efficient and differentiated operating models to improve women’s healthcare services throughout the region.”
Dr. Sawsan AS Al Madhi, Director General of Friends of Cancer Patients,Added: “Friends of Cancer Patients (FOCP) is a patient-centric organization. We fundamentally believe that in order to provide the best care, we must listen to patients and empower them. We welcome the Organon is launched in Turkey and we look forward to our cooperation to better understand and solve women’s unmet health needs.”
Relying on a dynamic business model and entrepreneurial approach, and in accordance with its commitment to accelerate the advancement of women’s health, the company also announced the launch of the Femtech accelerator program in the Middle East and North Africa with the early-stage venture capital firm Flat6Labs, which is the result of its first formal regional cooperation. The two companies will jointly support women-led and focused start-ups in the digital healthcare field and support them in the development of medium viable products (MVP). The selected start-ups will participate in a two-month intensive acceleration plan, which includes one-on-one coaching and guidance with relevant leading industry experts, online training, and docking with potential technology, investment and business partners.
[ad_2]
Source link